Marcio Souza - 18 Jun 2021 Form 3 Insider Report for Aeglea BioTherapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ Steven Weber, by power of attorney
Issuer symbol
SYRE
Transactions as of
18 Jun 2021
Net transactions value
$0
Form type
3
Filing time
22 Jun 2021, 16:06:26 UTC
Next filing
19 Aug 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.